Posted by : ZeroRisk Cases Marketing

New infant formula litigation has been developing over the last year involving two well-known formula products: Mead Johnson’s Enfamil and Abbott Laboratories’ Similac. The two cow milk-based infant formulas have been linked to the development of necrotizing enterocolitis (NEC) in premature infants.  This possibly fatal side effect has been known for a number of years; an article published as early as 1990 in the British medical journal, The Lancet, notes that NEC was more common in preterm infants who were fed formula as opposed to only breast milk or a mix of formula and breast milk.

NEC is an acute gastrointestinal condition in which harmful bacteria accumulates in an infant’s intestines causing inflammation, rupture, possible sepsis and tissue decay; it can occur in 1 out of every 1000 live births and is fatal in 15-40% of the cases. Because many babies who are born preterm cannot breastfeed, they are given formula to assist with their growth and development; this formula is typically made with cow milk and can lead to NEC. The National Institute of Child Health and Human Development estimates that NEC affects about 9,000 of the 480,000 infants born preterm each year in the United States; injuries can range from intestinal strictures that limit the baby’s ability to process food to tissue death, sepsis and even death.

;

The post New Infant Formula Lawsuits Forming Against Mead Johnson and Abbott Laboratories appeared first on Verus LLC.